Insider · CIK 0002103999
Bryan T Vaughn
Files at LH (LABORATORY CORP OF AMERICA HOLDINGS). First filing Jul 6, 2026, latest Jul 6, 2026.
In brief
Bryan T Vaughn files SEC Form 4 as officer at LH (LABORATORY CORP OF AMERICA HOLDINGS). Since Jul 6, 2026, Bryan T Vaughn has reported 0 open-market buys worth $0 and 1 open-market sell worth $67k, the latest filed on Jul 6, 2026.
A track record needs three past buys with six months of prices behind them; Bryan T Vaughn has 0, so none is measured yet.
The newest scored trade: sold $67k of LH on Jul 2, 2026, filed Jul 6, 2026, scored 0 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $67k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LH: LABORATORY CORP OF AMERICA HOLDINGS
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | LABORATORY CORP OF AMERICA HOLDINGS | $67k 234 shares | -3% | +19% from low-1% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 2, 2026 | LH LABCORP HOLDINGS INC. | 234 0.00% of outstanding | $67k | Jul 2, 2026 | none |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | AGrant or award Restricted Stock Unitderivative | +1,500 | $0.00 | $0 | 5,204 | 40 d ago |
| Jul 1, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Common Stock10b5-1 | +327 | - | - | 7,073 | Jul 6, 2026 |
| Jul 1, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | FTax withholding Common Stock10b5-1 | -93 | $283.88 | $26k | 6,980 | Jul 6, 2026 |
| Jul 2, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | SOpen-market sale Common Stock10b5-1 | -234 | $286.19 | $67k | 6,746 | Jul 6, 2026 |
| Jul 1, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Restricted Stock Unitderivative10b5-1 | -327 | $0.00 | $0 | 3,704 | Jul 6, 2026 |
| Mar 26, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | AGrant or award Common Stock | +1,584 | $0.00 | $0 | 7,197 | Mar 30, 2026 |
| Mar 26, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | FTax withholding Common Stock | -451 | $268.38 | $121k | 6,746 | Mar 30, 2026 |
| Feb 11, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Common Stock | +323 | - | - | 5,706 | Feb 13, 2026 |
| Feb 11, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | FTax withholding Common Stock | -93 | $289.89 | $27k | 5,613 | Feb 13, 2026 |
| Feb 11, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Restricted Stock Unitderivative | -323 | $0.00 | $0 | 4,031 | Feb 13, 2026 |
| Feb 10, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | AGrant or award Non-qualified Stock Optionsderivative | +2,200 | $0.00 | $0 | 2,200 | Feb 12, 2026 |
| Feb 10, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | AGrant or award Restricted Stock Unitderivative | +730 | $0.00 | $0 | 4,354 | Feb 12, 2026 |
| Feb 6, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Common Stock | +180 | - | - | 5,327 | Feb 10, 2026 |
| Feb 6, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | FTax withholding Common Stock | -61 | $277.20 | $17k | 5,266 | Feb 10, 2026 |
| Feb 7, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Common Stock | +178 | - | - | 5,444 | Feb 10, 2026 |
| Feb 9, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | FTax withholding Common Stock | -61 | $274.01 | $17k | 5,383 | Feb 10, 2026 |
| Feb 6, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Restricted Stock Unitderivative | -180 | $0.00 | $0 | 3,802 | Feb 10, 2026 |
| Feb 7, 2026 | LH LABORATORY CORP OF AMERICA HOLDINGS | MOption exercise Restricted Stock Unitderivative | -178 | $0.00 | $0 | 3,624 | Feb 10, 2026 |
Questions about Bryan T Vaughn
Answered from the filings on this page, as of the latest one.
Is Bryan T Vaughn buying or selling?
In the last 12 months Bryan T Vaughn reported 0 open-market buys worth $0 and 1 open-market sell worth $67k on SEC Form 4; the latest was sold $67k of LH on Jul 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Bryan T Vaughn's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bryan T Vaughn has 0.
Where does Bryan T Vaughn file Form 4?
Bryan T Vaughn has filed Form 4 at LH (LABORATORY CORP OF AMERICA HOLDINGS) as EVP and President, Diagnostics. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.